Health
Psychedelic drug discovery enabling discovery of new psychiatric drugs – Drug Target Review
Having resolved the structure of psychedelic drugs bound to the 5-HT2A serotonin receptor researchers are developing new therapeutic drugs.
Posted: 18 September 2020 | Hannah Balfour (Drug Target Review) | No comments yet
Having resolved the structure of psychedelic drugs bound to the 5-HT2A serotonin receptor researchers are now developing new therapeutic drugs.
Psychedelic drugs such as LSD, psilocybin, and mescaline cause severe and often long-lasting hallucinations, but also show great potential in treating serious psychiatric conditions, such as major depressive disorder. In order to understand their therapeutic effect, and p…
-
Noosa News23 hours ago‘Sunny, benign’ school holiday weather after morning showers in parts of Queensland
-
General18 hours agoDeveloper warns wind energy capacity may not be ready by WA coal deadline
-
General23 hours agoOlder Aussies back increased superannuation tax
-
Noosa News21 hours agoTips to improve engagement – Proctor